European Biotech Acquisition - Warrants (06/03/2026) Total Current Liabilities

The latest total current liabilities for EBACW is $800K as of December 2022. That compares with $510K in the prior-year period — up 57.5% year over year. Investors often review this figure alongside European Biotech Acquisition - Warrants (06/03/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, EBACW's total current liabilities moved from $510K to $800K — a 57.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in European Biotech Acquisition - Warrants (06/03/2026)'s operating scale or balance-sheet position.

A total current liabilities figure of $800K for EBACW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EBACW's total current liabilities ($800K), review year-over-year change from $510K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.